Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines

Human Vaccines and Immunotherapeutics - Tập 15 Số 2 - Trang 397-406 - 2019
Shuichi Hanada1, Tomoko Tsuruta1, Kouichi Haraguchi1, Masato Okamoto2, Haruo Sugiyama3, Shigeo Koido4,5
1Department of Hematology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
2Department of Advanced Immunotherapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan
3Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
4Division of Gastroenterology and Hepatology, Department of Hematology, The Jikei University School of Medicine, Kashiwa City, Chiba, Japan
5Institute of Clinical Medicine and Research, The Jikei University School of Medicine, Kashiwa City, Chiba, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1038/s41575-018-0005-x

10.1056/NEJMra0901557

10.1001/jama.2013.279201

10.1016/S0140-6736(16)30583-9

10.1016/S1470-2045(10)70237-0

Goldstein D, 2015, J Natl Cancer Inst, 107: dju413

10.1016/S0140-6736(16)32409-6

10.1200/JCO.2018.36.18_suppl.LBA4001

10.1245/s10434-009-0743-7

10.21037/jgo.2017.03.04

10.4161/hv.34392

Weinberg BA, 2015, Oncology (Williston Park, NY), 29, 86

10.1200/JCO.2016.67.5561

10.1038/nature06175

10.1080/2162402X.2017.1328341

10.3748/wjg.v22.i18.4446

10.1158/1078-0432.CCR-09-0737

Koido S, 2017, Discov Med, 24, 41

10.1007/s00262-011-1033-3

10.3892/ol.2018.8961

10.1038/ncomms5972

10.2217/imt-2016-0031

10.1016/S0091-6749(99)70489-6

10.1158/1078-0432.CCR-14-0314

10.4161/21624011.2014.958950

10.1111/bjh.12637

10.4049/jimmunol.174.3.1274

10.1002/ijc.28584

10.3748/wjg.v21.i9.2807

10.1371/journal.pone.0159447

10.1016/j.ccr.2009.06.017

10.1038/bjc.2013.595

10.1007/s11605-013-2286-2

10.1080/01635581.2016.1250921

10.1038/sj.bjc.6605855

Thông tin
Thông tin xuất bản

Human Vaccines and Immunotherapeutics

Tập 15 Số 2

397-406

Thông tin tác giả